* Lugano Lymphoma (updated 2024-11-21) ~ youtor.org

Lugano Lymphoma (updated 2024-11-21)

Lugano staging for Gastrointestinal Lymphoma [upl. by Atikim]

Lugano staging for Gastrointestinal Lymphoma

Duration: 2:26
9 views | 2 months ago

The role of the tumor microenvironment in splenic MZL Treg expression [upl. by Aneelahs287]

The role of the tumor microenvironment in splenic MZL Treg expression

Duration: 1:21
278 views | 15 Jun 2023

The possibility of moving away from radiation therapy in pediatric patients with Hodgkin lymphoma [upl. by Varick989]

The possibility of moving away from radiation therapy in pediatric patients with Hodgkin lymphoma

Duration: 1:17
136 views | 31 Jul 2023

SUNMO mosunetuzumab polatuzumab vedotin vs RGemOx in RR aggressive NHL [upl. by Ahsal]

SUNMO mosunetuzumab polatuzumab vedotin vs RGemOx in RR aggressive NHL

Duration: 0:49
146 views | 1 Aug 2023

OLYMPIA5 odronextamab lenalidomide for RR indolent lymphoma [upl. by Akeinahs628]

OLYMPIA5 odronextamab lenalidomide for RR indolent lymphoma

Duration: 1:21
142 views | 21 Jul 2023

Using GEP to molecularly characterize amp predict the outcomes of patients with PMBCL [upl. by Fariss]

Using GEP to molecularly characterize amp predict the outcomes of patients with PMBCL

Duration: 2:15
60 views | 22 Jun 2023

LUGANO classification [upl. by Dobb]

LUGANO classification

Duration: 5:39
1.8K views | 17 Jun 2021

Follicular lymphoma the value of immunotherapies amp other exciting areas of research [upl. by Ko]

Follicular lymphoma the value of immunotherapies amp other exciting areas of research

Duration: 1:52
918 views | 1 Aug 2023

ROBUST study why did it not meet its primary endpoint A subgroup analysis [upl. by Kape]

ROBUST study why did it not meet its primary endpoint A subgroup analysis

Duration: 6:59
172 views | 21 Jun 2019

The importance of understanding the TME amp using this to guide treatment for Bcell lymphomas [upl. by Millian]

The importance of understanding the TME amp using this to guide treatment for Bcell lymphomas

Duration: 1:32
349 views | 11 Jul 2023

RCHOP v RCHOP Lenalidomide For Diffuse Large BCell Lymphoma [upl. by Ayrotal175]

RCHOP v RCHOP Lenalidomide For Diffuse Large BCell Lymphoma

Duration: 2:13
806 views | 17 Jun 2015

Timelimited therapy in CLL [upl. by Assyn]

Timelimited therapy in CLL

Duration: 1:24
93 views | 28 Jun 2019

Agressive or transformed MCL prognostic factors outcomes amp mutational profile

Duration: 2:18
334 views | 2 Jul 2019

ViPOR regimen for RR Bcell lymphoma [upl. by Malita448]

ViPOR regimen for RR Bcell lymphoma

Duration: 2:30
447 views | 2 Jul 2019

The Tcell lymphoma project prospective data collection changing the world [upl. by Azmuh441]

The Tcell lymphoma project prospective data collection changing the world

Duration: 2:11
65 views | 28 Jun 2019

Fixedduration treatment strategies for frontline and relapsed CLL [upl. by Brandenburg613]

Fixedduration treatment strategies for frontline and relapsed CLL

Duration: 0:56
171 views | 28 Jul 2023

Nextgeneration CAR Tcells for lymphoma and beyond [upl. by Otreblada]

Nextgeneration CAR Tcells for lymphoma and beyond

Duration: 3:24
87 views | 28 Jun 2019

CLL highlights from EHA and ICML the CLL12 study [upl. by Nere543]

CLL highlights from EHA and ICML the CLL12 study

Duration: 1:07
142 views | 5 Jul 2023

Challenges in understanding the genomic landscape of Hodgkin lymphoma [upl. by Finegan70]

Challenges in understanding the genomic landscape of Hodgkin lymphoma

Duration: 1:27
79 views | 21 Jul 2023

Follicular lymphoma BR in the frontline and pretreatment PET [upl. by Hellman]

Follicular lymphoma BR in the frontline and pretreatment PET

Duration: 7:17
368 views | 1 Jul 2019

Loncastuximab tesirine longterm survival data from LOTIS2 amp insights into the LOTIS7 trial [upl. by Nnarefinnej]

Loncastuximab tesirine longterm survival data from LOTIS2 amp insights into the LOTIS7 trial

Duration: 1:09
227 views | 1 Aug 2023

Will the updated Lugano Classification System for HL and NonHL change how clinicians practice [upl. by Ellison]

Will the updated Lugano Classification System for HL and NonHL change how clinicians practice

Duration: 3:20
713 views | 28 Apr 2016

Treatment of aggressive NHL in frail patients cardiac comorbidities and advanced age [upl. by Dinan]

Treatment of aggressive NHL in frail patients cardiac comorbidities and advanced age

Duration: 2:07
68 views | 1 Jul 2019

Chemotherapyfree treatment for MCL success from the WINDOW2 trial [upl. by Ostap]

Chemotherapyfree treatment for MCL success from the WINDOW2 trial

Duration: 1:39
445 views | 27 Jul 2023

CLL14 venetoclaxobinutuzumab improves PFS and MRD in untreated reduced fitness CLL [upl. by Namrehs]

CLL14 venetoclaxobinutuzumab improves PFS and MRD in untreated reduced fitness CLL

Duration: 1:16
279 views | 20 Jun 2019

Differences between NLPHL and classical HL amp promising treatment approaches for NLPHL [upl. by Hale]

Differences between NLPHL and classical HL amp promising treatment approaches for NLPHL

Duration: 1:25
604 views | 27 Jul 2023

Women leaders in lymphoma [upl. by Llebyram]

Women leaders in lymphoma

Duration: 1:14
76 views | 28 Jun 2019

BRAWM bendamustine rituximab and acalabrutinib for Waldenström’s macroglobulinemia [upl. by Immat529]

BRAWM bendamustine rituximab and acalabrutinib for Waldenström’s macroglobulinemia

Duration: 4:33
746 views | 24 Jul 2023

Impaired immunity in DLBCL survivors [upl. by Thorsten]

Impaired immunity in DLBCL survivors

Duration: 3:04
1.5K views | 2 Jul 2019

Misconceptions about the use of biosimilars [upl. by Kaz]

Misconceptions about the use of biosimilars

Duration: 1:23
64 views | 19 Jun 2017

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024